Preterm birth represents a major US public health problem, with 1 in 10 neonates born before 37 weeks’ gestation in 2018, placing them at a greater risk of death and disability.
So it’s not surprising that pregnant women who’ve already spontaneously delivered a baby preterm would be eager for a treatment that promises to help them get closer to term. Same goes for their physicians.
Rubin R. Confirmatory Trial for Drug to Prevent Preterm Birth Finds No Benefit, So Why Is It Still Prescribed? JAMA. 2020;323(13):1229–1232. doi:10.1001/jama.2020.1486
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: